#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bronchiolitis Thrombotic thrombocytopenic purpura T-cell type acute leukaemia Malignant glioma Niemann-Pick disease Extra-osseous Ewing's sarcoma metastatic PIK3CA related overgrowth spectrum Immune-mediated myasthenia gravis Trigeminal neuralgia Scedosporium infection Hypochondroplasia Infertility male Cutaneous lupus erythematosus Oesophageal squamous cell carcinoma stage III Lupus nephritis More trials…

    Learn about Rare Diseases

    Glomerulonephritis rapidly progressive – Treatment Choroid melanoma – Life with Disease Rosai-Dorfman syndrome – Trials in Disease Anaplastic thyroid cancer – Diagnostics Familial amyotrophic lateral sclerosis – Treatment Hyperoxaluria – Treatment Isodicentric chromosome 15 syndrome – Diagnostics Alport’s syndrome – Diagnostics X-linked lymphoproliferative syndrome Haemophilia A with anti factor VIII More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    INOBRODIB Tyrosine Bay 2927088 Enx-101 Ribonucleic Acid K30 Ublituximab Tozorakimab 99MTC-EUK-(SO3)CY5-MAS3 Nimodipine Cd19-Car_Lenti_Allo Ketamine Hydrochloride CAMOSTAT MESILATE Aaa802 VG801-2 Dapagliflozin Carbetocin Deflazacort Pelacarsen Oxymetazoline Hydrochloride Poltreg-T1D More therapies…

    Learn about Your Condition

    Pulmonary tuberculosis Adenocarcinoma pancreas Malignant melanoma of eyelid Endocarditis bacterial Procedural anxiety Takayasu's arteritis Skin bacterial infection Arterial disorder Right ventricular dysfunction Invasive breast carcinoma Hypotonia Meningococcal infection Neuromuscular scoliosis Latent tuberculosis HIV infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of mRNA-4157 and BCG for Patients with High-Risk Non-Muscle Invasive Bladder Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Mrna-4157
    Denmark France Germany Greece Hungary Italy +3

  • Study of Tarlatamab for Patients with Metastatic or Advanced Small-Cell Lung Cancer and Neuroendocrine Carcinomas

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neuroendocrine carcinoma
    • Small cell lung cancer metastatic
    Investigated Drugs:
    • Tarlatamab
    France Germany

  • Study on Sotatercept for Improving Heart Function in Patients with Pulmonary Arterial Hypertension

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Sotatercept
    The Netherlands

  • Study of HLX22, Trastuzumab, and Chemotherapy for Patients with Advanced or Metastatic Stomach and Gastroesophageal Cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Gastric cancer
    • Metastatic gastric cancer
    • Oesophageal cancer metastatic
    Investigated Drugs:
    • HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2
    • Pembrolizumab
    Germany Greece Italy Poland Portugal Romania +1

  • Study on IV NEPA (Fosnetupitant/Palonosetron) for Preventing Chemotherapy-Induced Nausea and Vomiting in Pediatric Cancer Patients

    Recruiting

    4 1 1
    Investigated Diseases:
    • Prophylaxis of nausea and vomiting
    Investigated Drugs:
    • 204-NETU
    • Fosaprepitant
    • Ondansetron
    Greece Poland Romania

  • Study on Cemiplimab and OSE2101 for Maintenance Therapy in Patients with ctDNA Positive Non-Small Cell Lung Cancer (NSCLC)

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Cemiplimab
    • D-Ala-Lys-Cha-Val-Ala-Ala-Trp-Thr-Leu-Lys-Ala-Ala-D-Ala
    • Mps-102
    Italy
Previous Page
1 … 223 224 225 226 227 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!